Home » Topics » BioWorld Science

BioWorld Science
RSS

Cetiedil analogue with increased potency for blocking RBC Ca2+-activated K+ permeability

Oct. 1, 2001

Selective Gardos channel inhibitors useful in sickle cell disease

Sep. 28, 2001

New series from Teijin inhibits human chymase, particularly mast cell enzyme

Sep. 28, 2001

Eisai presents new sodium channel inhibitors with antiarrhythmic activity

Sep. 28, 2001

Daiichi's new squalene synthase and cholesterol biosynthesis inhibitors patented

Sep. 28, 2001

Potent and selective MCP-1 antagonists identified by Daiichi

Sep. 28, 2001

1-Methylcarbapenems with excellent antibacterial activity, safety and pharmacokinetics

Sep. 28, 2001

New dopamine D4 ligands from Lundbeck and potential therapeutic uses

Sep. 28, 2001

New PDE4 inhibitor CI-1044 may be useful in COPD, according to ERS presentation

Sep. 28, 2001

ERS highlights: NIK-616 may have advantages for Rx of asthma and COPD

Sep. 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...